BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18321753)

  • 21. Donepezil for memory dysfunction in schizophrenia.
    Howard AK; Thornton AE; Altman S; Honer WG
    J Psychopharmacol; 2002 Sep; 16(3):267-70. PubMed ID: 12236636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report.
    Rao NP; Palaniyappan P; Chandur J; Venkatasubramanian G; Gangadhar BN
    J ECT; 2009 Sep; 25(3):216-8. PubMed ID: 19190508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donepezil-related intractable hiccups: a case report.
    McGrane IR; Shuman MD; McDonald RW
    Pharmacotherapy; 2015 Mar; 35(3):e1-5. PubMed ID: 25756505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of donepezil and neostigmine in a patient with unusual pseudocholinesterase activity.
    Sprung J; Castellani WJ; Srinivasan V; Udayashankar S
    Anesth Analg; 1998 Nov; 87(5):1203-5. PubMed ID: 9806710
    [No Abstract]   [Full Text] [Related]  

  • 25. Calculate the QT interval in patients taking drugs for dementia.
    Leitch A; McGinness P; Wallbridge D
    BMJ; 2007 Sep; 335(7619):557. PubMed ID: 17855324
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacological treatment of cognitive deficits in Alzheimer's disease.
    Lam W
    Med J Aust; 2002 Mar; 176(6):297; author reply 297-8. PubMed ID: 11999269
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatotoxicity Associated with Donepezil in an Individual Taking Citalopram.
    Ma L; Wen C; Chen C; Shen S; Yang J
    J Am Geriatr Soc; 2016 May; 64(5):1144-5. PubMed ID: 27225372
    [No Abstract]   [Full Text] [Related]  

  • 28. Scopolamine-induced deficits in social memory in mice: reversal by donepezil.
    Riedel G; Kang SH; Choi DY; Platt B
    Behav Brain Res; 2009 Dec; 204(1):217-25. PubMed ID: 19527754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A patient with probable dementia with Lewy bodies, who showed catatonia induced by donepezil: a case report].
    Morita S; Miwa H; Kondo T
    No To Shinkei; 2004 Oct; 56(10):881-4. PubMed ID: 15609676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
    Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
    Doody RS; Ferris SH; Salloway S; Sun Y; Goldman R; Watkins WE; Xu Y; Murthy AK
    Neurology; 2009 May; 72(18):1555-61. PubMed ID: 19176895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan.
    Nozawa M; Ichimiya Y; Nozawa E; Utumi Y; Sugiyama H; Murayama N; Iseki E; Arai H
    Psychogeriatrics; 2009 Jun; 9(2):50-5. PubMed ID: 19604325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Ohbayashi T
    Dement Geriatr Cogn Disord; 2008; 25(5):399-407. PubMed ID: 18391486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results, rhetoric, and randomized trials: the case of donepezil.
    Gilstad JR; Finucane TE
    J Am Geriatr Soc; 2008 Aug; 56(8):1556-62. PubMed ID: 18662199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
    Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The changes of cortical metabolism associated with the clinical response to donepezil therapy in traumatic brain injury.
    Kim YW; Kim DY; Shin JC; Park CI; Lee JD
    Clin Neuropharmacol; 2009; 32(2):63-8. PubMed ID: 18978490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occupational contact urticaria caused by donepezil.
    Galvez Lozano JM; Alcantara M; De San Pedro BS; Quiralte J; Caba I
    Contact Dermatitis; 2009 Sep; 61(3):176. PubMed ID: 19780775
    [No Abstract]   [Full Text] [Related]  

  • 38. Mayo Clinic office visit. Mild cognitive impairment. An interview with Ronald Petersen, M.D., Ph.D.
    Petersen R
    Mayo Clin Womens Healthsource; 2006 Nov; 10(11):7-8. PubMed ID: 17047568
    [No Abstract]   [Full Text] [Related]  

  • 39. Donepezil: syncope. Various cardiac disorders.
    Prescrire Int; 2008 Jun; 17(95):113. PubMed ID: 18630357
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of donepezil on verbal memory after semantic processing in healthy older adults.
    FitzGerald DB; Crucian GP; Mielke JB; Shenal BV; Burks D; Womack KB; Ghacibeh G; Drago V; Foster PS; Valenstein E; Heilman KM
    Cogn Behav Neurol; 2008 Jun; 21(2):57-64. PubMed ID: 18541979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.